Nyra Medical
PrivateLast Round
Series A
Nov 23, 2022
Total Funding Raised
$20M
Company Overview
Nyra Medical operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Series A round in November 2022.
Nyra Medical is a clinical-stage medical device company that develops transcatheter solutions to restore valve function while preserving natural physiology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nyra Medical Comparables
Compare Nyra Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Polares Medical | 88% | |
| Sutra Medical, Inc. | 85% | |
| Versa Vascular, Inc. | 78% |
For institutional investors. Book with your work email.
Nyra Medical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nyra Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Series A |
| Vensana Capital | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Cardiac Leaflet Enhancer (CARLEN) is an investigational medical device.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 27, 2026
Nyra Medical, Inc. appoints Scott Tyler as Senior Director of Clinical Engineering and Development to support clinical execution and product development as it advances its U.S. Early Feasibility Study in Georgia on Oct 27th '26.
- hiresOct 27, 2026
Nyra Medical, Inc. appoints Suzanne Wallace, CRNP, as Vice President of Clinical and Market Development in Georgia on Oct 27th '26, strengthening its leadership team as it advances enrollment and clinical execution in its U.S. Early Feasibility Study of the investigational CARLEN System.
For institutional investors. Book with your work email.
Nyra Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nyra Medical's valuation, stock price, and market status.
Is Nyra Medical a public or private company?
Nyra Medical is a private company.
What is the current stock price of Nyra Medical?
Nyra Medical is a private company, so its shares have no public market price. Caplight tracks Nyra Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nyra Medical worth (valuation)?
Valuation information for Nyra Medical is not publicly available.
Can I buy Nyra Medical stock?
Nyra Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nyra Medical's last funding round?
Nyra Medical's most recent funding round was Series A on November 23, 2022.
Who are the main investors in Nyra Medical?
Key investors in Nyra Medical include Vensana Capital.
Will Nyra Medical IPO soon?
No public IPO plans have been announced for Nyra Medical.
How can I track Nyra Medical secondary market activity?
Caplight tracks bids, offers, and trades in Nyra Medical's shares on secondary markets.